Mealey's (December 19, 2018, 8:48 AM EST) -- TRENTON, N.J. — A New Jersey federal judge on Nov. 13 denied certification of a class action alleging that consumers received a cholesterol drug made by generic manufacturer Ranbaxy Pharmaceuticals Inc. that contained small particles of glass (Francis Fenwick, et al. v. Ranbaxy Pharmaceuticals, Inc., et al., No. 12-7354, D. N.J., 2018 U.S. Dist. LEXIS 194780)....